Moleculin Biotech ( (MBRX) ) has provided an update.
Moleculin Biotech, Inc. has recently updated its corporate presentation on the company’s website, offering insights into its latest developments and strategic direction. Although this information, presented on September 16, 2024, is available for public view, it is not officially filed under the securities laws and should not be considered as part of its formal financial disclosures. This move caters to investors’ growing interest in the biotech sector, providing an easily accessible resource to stay informed about the company’s progress.
For a thorough assessment of MBRX stock, go to TipRanks’ Stock Analysis page.
